1. Home
  2. NBIX vs SBS Comparison

NBIX vs SBS Comparison

Compare NBIX & SBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • SBS
  • Stock Information
  • Founded
  • NBIX 1992
  • SBS 1954
  • Country
  • NBIX United States
  • SBS Brazil
  • Employees
  • NBIX N/A
  • SBS N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • SBS Water Supply
  • Sector
  • NBIX Health Care
  • SBS Utilities
  • Exchange
  • NBIX Nasdaq
  • SBS Nasdaq
  • Market Cap
  • NBIX 13.1B
  • SBS 11.6B
  • IPO Year
  • NBIX 1996
  • SBS 2002
  • Fundamental
  • Price
  • NBIX $134.99
  • SBS $13.94
  • Analyst Decision
  • NBIX Buy
  • SBS
  • Analyst Count
  • NBIX 23
  • SBS 0
  • Target Price
  • NBIX $165.00
  • SBS N/A
  • AVG Volume (30 Days)
  • NBIX 884.4K
  • SBS 896.5K
  • Earning Date
  • NBIX 02-05-2025
  • SBS 02-06-2025
  • Dividend Yield
  • NBIX N/A
  • SBS 1.90%
  • EPS Growth
  • NBIX 97.40
  • SBS 213.18
  • EPS
  • NBIX 3.73
  • SBS 2.51
  • Revenue
  • NBIX $2,242,800,000.00
  • SBS $6,532,815,340.00
  • Revenue This Year
  • NBIX $27.07
  • SBS N/A
  • Revenue Next Year
  • NBIX $16.60
  • SBS $11.81
  • P/E Ratio
  • NBIX $36.67
  • SBS $5.85
  • Revenue Growth
  • NBIX 25.72
  • SBS 46.76
  • 52 Week Low
  • NBIX $110.95
  • SBS $13.10
  • 52 Week High
  • NBIX $157.98
  • SBS $18.36
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 73.61
  • SBS 38.74
  • Support Level
  • NBIX $125.61
  • SBS $14.37
  • Resistance Level
  • NBIX $130.48
  • SBS $15.02
  • Average True Range (ATR)
  • NBIX 2.67
  • SBS 0.38
  • MACD
  • NBIX 0.90
  • SBS -0.09
  • Stochastic Oscillator
  • NBIX 95.47
  • SBS 21.05

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

About SBS Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (Each repstg 250)

Companhia De Saneamento Basico Do Estado De Sao Paulo is engaged in the provision of basic and environmental sanitation services in the Sao Paulo State and supplies treated water and sewage services on a wholesale basis. The company operates in a single segment, which is Sanitation services.

Share on Social Networks: